Edition:
India

Aclaris Therapeutics Announces Availability Of Eskata In The U.S.


Monday, 7 May 2018 

May 7 (Reuters) - Aclaris Therapeutics Inc ::ACLARIS THERAPEUTICS ANNOUNCES AVAILABILITY OF ESKATA™ (HYDROGEN PEROXIDE) TOPICAL SOLUTION, 40% (W/W).ACLARIS THERAPEUTICS INC - ESKATA IS NOW AVAILABLE FOR PURCHASE BY DERMATOLOGISTS IN THE UNITED STATES. 

Company Quote

5.52
0.33 +6.36%
1:30am IST